Navigation Links
Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008
Date:7/29/2008

Reconciliation of GAAP Net Income to Adjusted Net Income

(Unaudited)

Three Months Ended

June 30,

2008 2007

GAAP NET INCOME $ 60,068 $ (4,308)

Cost of sales adjustments 28,892(1) 21,016(1)

Research and development adjustments - 16,500(2)

Settlement reserve - 56,000(3)

Gain on sale of investment - (5,791)(4)

Interest expense adjustment 3,750(5) -

Restructuring adjustment 1,565(6) -

Income tax adjustment (9,814)(7) (7,784)(7)

24,393 79,941

ADJUSTED NET INCOME $ 84,461 $ 75,633

BASIC ADJUSTED INCOME PER COMMON SHARE $1.25 $1.14

DILUTED ADJUSTED INCOME PER COMMON SHARE $1.13 $0.93

WEIGHTED AVERAGE NUMBER OF COMMON

SHARES OUTSTANDING 67,777 66,445

WEIGHTED AVERAGE NUMBER OF COMMON

SHARES OUTSTANDING-ASSUMING DILUTION 74,852 81,209

Notes to Reconciliation of GAAP Net Income to Adjusted Net Income

(1) To exclude the on-going amortization of acquired intangible assets

($26.8 million in 2008; $21.0 million in 2007), and accelerated

depreciation related to restructuring ($2.1 million in 2008).

(2) To exclude charges related to payments for several research and

development collaborations.

(3) To exclude the reserve established for the minimum liabilit
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Announces Strong Third Quarter Financial Results
7. Cephalon Submits Supplemental New Drug Application for FENTORA
8. Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkins Lymphoma
9. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
10. Cephalons EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
11. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... a number of significant technological challenges in their ... originally created for the James Webb Space Telescope. ... Moseley, a scientist at NASA,s Goddard Space Flight ... actuated microshutter arrays that is, those activated ... functional as the current technology,s magnetically activated arrays. ...
(Date:7/29/2014)... HOUSTON (July 29, 2014) Tough, ultralight foam ... and shape through a chemical process invented at Rice ... "GO-0.5BN" looks like a nanoscale building, with floors and ... a pair of two-dimensional materials: floors and walls of ... boron nitride platelets. , The researchers say the ...
(Date:7/29/2014)... 29, 2014 According to the ... Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/Cloud ... & Trends to 2018", published by MarketsandMarkets, analyzes and ... such as North America , ... and the Rest of the World (RoW). ...
(Date:7/29/2014)... HILLS, Calif. , July 29, 2014 /PRNewswire/ ... specializing in personalized medicine, treatment of infectious diseases ... strategies of prognosis and prevention of pathologies like ... of August 1, 2014, ImmunoClin Corporation will complete ... Washington, D.C. , a key ...
Breaking Biology Technology:Revolutionary microshutter technology hurdles significant challenges 2Revolutionary microshutter technology hurdles significant challenges 3Revolutionary microshutter technology hurdles significant challenges 4Tough foam from tiny sheets 2Digital Pathology Market worth $437 Million by 2018 2Digital Pathology Market worth $437 Million by 2018 3ImmunoClin Corporation (IMCL) Relocates Corporate Headquarters to Washington, DC 2ImmunoClin Corporation (IMCL) Relocates Corporate Headquarters to Washington, DC 3
... Inc., (TSX: IXS.V, OTC Bulletin Board: IXSBF, http://www.ixsbio.com ... of monoclonal antibodies based on its Dynamic Cross ... of Directors., Mr. Warden was a founding ... 23 years of practice, he has represented both ...
... SHANGHAI, China, Sept. 9 /Xinhua-PRNewswire-FirstCall/ --,China-Biotics, Inc. ... leading Chinese firm specializing in the manufacture,research, ... announced it has begun to install equipment ... facility, occupying approximately 789,000 square feet, is,located ...
... SectorWatch.biz announces the,availability of MarketStats for ... today. MarketStats offers a perspective on the,aforementioned ... respond with,articles, blogs and opinions., Investors ... ,-- a division of FiSpace.net, a dynamic ...
Cached Biology Technology:InNexus Biotechnology Strengthens Patent Team With New Leadership 2China-Biotics, Inc. Provides Update on Construction of New Manufacturing Facility 2SectorWatch.biz Issues MarketStats on Agri-Biotech Equities YGYB, GRO, SEED, MON, ADM, and BG 2
(Date:7/29/2014)... Francisco is the first to show that while the ... aging, these negative effects may be reduced by maintaining ... "The study participants who exercised, slept well and ate ... didn,t maintain healthy lifestyles, even when they had similar ... assistant professor in the department of psychiatry at UCSF. ...
(Date:7/28/2014)... States have a circulatory problem of the legs called ... even require surgery in serious cases. This disease can ... limb amputation. , At The University of Texas Health ... a non-surgical preventative treatment in a mouse model of ... circulation. Their proof-of-concept study appears in the journal ...
(Date:7/28/2014)... , a wild relative of the domestic tomato, has ... the labs headed by Professors Neelima Sinha and Julin ... The new genome information may help breeders produce tastier, ... in the journal Nature Genetics , was lead ... Germany. The UC Davis labs carried out work on ...
Breaking Biology News(10 mins):Healthy lifestyle may buffer against stress-related cell aging, study says 2Scientists discover genetic switch that can prevent peripheral vascular disease in mice 2
... hydrocarbons (PAHs) are components of petroleum products such as ... by-products of the combustion of fuels including petroleum and ... effects. Because they are produced during combustion, they are ... a concern in all urban waterways. However, because there ...
... is gaining credibility in Western medicine for anticancer powers ... of Florida researcher Nam Dang, M.D., Ph.D., and colleagues ... a broad range of lab-grown tumors, including cancers of ... used an extract made from dried papaya leaves, and ...
... Research Centre of Finland will establish a Centre of Water ... water sector is being gathered into one centre. The aim ... water sector in Finland and to create new business opportunities ... centre will be known as the Centre of Water Efficiency ...
Cached Biology News:Sources of pollution in waterways 2Papaya extract thwarts growth of cancer cells in lab tests 2Finland to get a Center of Water Efficiency Excellence 2
Direct ELISA Assay Diluent - EDTA, 10 L...
... Turn routine agarose gel electrophoresis into ... 96 system. This bufferless, pre-cast system is ... preparations, restriction digests, and more. Fully automated, ... the E-Gel 96 system makes your high-throughput ...
SpectroQuest single beam 4nm UV/Vis spectrophotometer; stand-alone unit; large angled LCD screen; large sample compartment...
... Cloning Kit, 40 reactions. Optimized for ... all PCR products with blunt or ... by offering consistently better signal-to-noise ratios ... positive clones.Amplicons generated by proof-reading thermostable ...
Biology Products: